Toxic effects of decabromodiphenyl ether (BDE-209) on human embryonic kidney cells by Min Li et al.
ORIGINAL RESEARCH ARTICLE
published: 06 May 2014
doi: 10.3389/fgene.2014.00118
Toxic effects of decabromodiphenyl ether (BDE-209) on
human embryonic kidney cells
Min Li1, Zhenping Liu1, Liang Gu1, Rong Yin2, Huarong Li3, Xiaobai Zhang1, Tongcheng Cao2* and
Cizhong Jiang1*
1 Shanghai Tenth People’s Hospital, Shanghai Key Laboratory of Signaling and Disease Research, The School of Life Sciences and Technology, Tongji University,
Shanghai, China
2 Department of Chemistry, Tongji University, Shanghai, China
3 Department of Otorhinolaryngology, Jianyang Municipal Hospital, Jianyang, China
Edited by:
Ji Qi, Fudan University, China
Reviewed by:
Wu Xu, University of Louisiana at
Lafayette, USA
Rongxin Zhang, Tianjin Medical
University, China
*Correspondence:
Cizhong Jiang, The School of Life
Sciences and Technology, Tongji
University, 1239 Siping Road,
Shanghai, 200092, China
e-mail: czjiang@tongji.edu.cn;
Tongcheng Cao, Department of
Chemistry, Tongji University, 1239
Siping Road, Shanghai, 200092,
China
e-mail: ctc@tongji.edu.cn
Polybrominated diphenyl ethers (PBDEs) are widely used as flame-retardant additives
in consumer and household products and can escape into the environment over time.
PBDEs have become a global environmental organic pollutant due to the properties of
persistence, toxicity, and bioaccumulation. The well-studied toxic effects of PBDEs mainly
include thyroid hormone disruption and neurotoxicity. There is no consistent conclusions
on the carcinogenic potential of PBDEs to date. Here, we explored the toxic effects
of BDE-209 on human embryonic kidney cells (HEK293T). The comparison of the gene
expression profiles of HEK293T cells with BDE-209 treatment and the negative control
found that BDE-209 exposure may alter nucleosome organization through significantly
changing the expression of histone gene clusters. The remodeled chromatin structure
could further disturb systemic lupus erythematosus as one of the toxic effects of
BDE-209. Additionally, gene sets of different cancer modules are positively correlated with
BDE-209 exposure. This suggests that BDE-209 has carcinogenic potential for a variety of
tumors. Collectively, BDE-209 has a broader toxicity not limited to disruption of thyroid
hormone-related biological processes. Notably, the toxic effects of BDE-209 dissolved in
dimethyl sulfoxide (DMSO) is not the simply additive effects of BDE-209 and DMSO alone.
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INTRODUCTION
Polybrominated diphenyl ethers (PBDEs) are a major type of
brominated flame retardants. PBDEs have been widely used in a
variety of consumer and household products to delay the igni-
tion of materials (Birnbaum et al., 2003; Hale et al., 2003). The
previous study reported that PBDEs in the household goods
could leach into the environment (Kim et al., 2006). It has
been reported that PBDEs were detected in house dust samples
(Stapleton et al., 2005). Because of its persistence, toxicity, and
bioaccumulative nature, PBDEs have become global environmen-
tal contaminants (Costa and Giordano, 2007; Tseng et al., 2008).
PBDE residues have been detected in serum, breast milk, and adi-
pose tissue from individuals (Birnbaum et al., 2003; McDonald,
2005). Moreover, concentrations of PBDEs in human and animal
bodies are increasing (McDonald, 2002).
The toxic effects of PBDEs can lead to thyroid hormone
disruption, neurobehavioral toxicity, and cancer. The chemical
structure of PBDEs is very similar to that of the thyroid
hormones (TH), 3,3′,5-triiodothyronine (T3) and 3,3′,5,5′-
tetraiodothyronine (T4). The metabolites of PBDEs compete
with thyroid hormones to bind to thyroid hormone receptors
(TR) (Marsh et al., 1998)and thyroid hormone transport pro-
teins (Meerts et al., 2000). As a consequence, PBDEs disrupt TH
homeostasis. The T4 level was decreased in rats and mice follow-
ing oral administration of PBDEs (Fowles et al., 1994; Darnerud
and Sinjari, 1996). Another possible mechanism of thyroid hor-
mone disruption is that PBDEs could induce different families of
liver enzymes (Von Meyerinck et al., 1990; Fowles et al., 1994;
Zhou et al., 2001). Thus, PBDEs may alter many signal trans-
duction pathways regaled by TH at multiple levels. For example,
PBDEs significantly suppressed Purkinje cell dendrite arboriza-
tion by disrupting TR-mediated transcription (Ibhazehiebo et al.,
2011).
Studies showed that PBDE exposure exerted neurotoxicity. TH
regulates the development of the nervous system at multiple lev-
els, including proliferation of neuronal and glial cells, cytoskeletal
assembly and stability essential for migration and neuronal out-
growth (Porterfield, 2000). Therefore, the normal TH levels are
critical for proper brain development (Porterfield and Hendrich,
1993; Morreale De Escobar et al., 2000). Transthyretin, the TH
transport protein, functions in delivering TH to the fetus from
the mother during gestation (Brouwer et al., 1998). As introduced
above, TH could compete with TH for transthyretin and cause
TH imbalance that could adversely affect brain development. A
study of neurobehavioral effects of PBDEs found that abnormal
TH level in the mother usually results in reduced intelligence in
progeny (Morreale De Escobar et al., 2000). More studies showed
that newborns exposed in PBDEs developed learning and motor
deficits as they grew older (Eriksson et al., 1998, 1999; McDonald,
2002).
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There is evidence indicating the carcinogenic potential of
the fully brominated deca-BDE (NTP, 1986). The national tox-
icology program (NTP) found clear correlation between PBDE
dose increase and liver neoplastic nodules in rats. The pro-
gram study also showed the increased acinar cell adenoma of
the pancreas in male rats treated with high-dose PBDEs. In con-
trast, only marginal increases in liver and thyroid tumors were
observed to be related to deca-BDE. Interestingly, another ear-
lier bioassay in rats with much lower dose of deca-BDE did
not found statistically significant increases in tumors (Kociba
et al., 1975). The lower molecular weight PBDEs (tri- to hexa-
BDEs) are more bioaccumulative than deca-BDE. Unfortunately,
there is only limited data regarding carcinogenicity of these
more bioaccumulative PBDEs. Therefore, more studies should
be undertaken to understand the carcinogenic potential of
PBDEs.
In this study, we employed the high-throughput technology
RNA-seq to profile the global gene expression of human embry-
onic kidney cells (HEK293T) cultured in the normal medium,
and the medium added with DMSO (the solvent) and with BDE-
209 dissolved in DMSO. Pairwise comparisons identified signifi-
cantly expressed genes between each two samples. The functional
analysis of these genes found that BDE-209 exposure may alter
nucleosome arrangement through changing the expression of his-
tone gene clusters. In addition to this, BDE-209 exposure could
increase the risk for tumorigenesis of a number of tumors. Our
results also found that the total toxic effects of BDE-209 dissolved
in DMSO led to a more complex toxic effects than the additive
effects of BDE-209 and DMSO alone.
MATERIALS AND METHODS
CELL CULTURE AND BDE-209 TREATMENT
We cultured human embryonic kidney 293 cells (HEK293T) at
37◦C in 5% CO2 as adherent monolayer in Dulbecco modi-
fied Eagle medium (DMEM) (Hyclone) that was supplemented
with L-glutamine and 10% fetal bovine serum (FBS) (Hyclone).
BDE-209 was dissolved in the dimethyl sulfoxide (DMSO) and
added to the culture medium. The final concentration of BDE-
209 and DMSO is 10−6 and 10−3 M, respectively. The negative
control is the HEK293T cells cultured in the normal medium. The
DMSO treatment sample is the HEK293T cells cultured in the
medium added with DMSO. The BDE-209 treatment sample is
the HEK293T cells cultured in the medium added with BDE-209
dissolved in DMSO. All samples were cultured for 48 h.
RNA-seq EXPERIMENT
We extracted the total RNA w from each sample using Trizol
reagent (Invitrogen) according to the manufacturer’s instruc-
tions. Then, BGI-Shenzhen (the sequencing service provider)
enriched the mRNA by polyA tail, prepared the library, and did
the sequencing using Illumina HiSeq2000. Sequencing method
was 49 bp single-end reads. RNA-seq data can be accessed through
GEO database under accession number GSE56361.
BIOINFORMATICS ANALYSIS
RNA-seq reads were aligned to the hg19 genome with
SOAPaligner-v2.21 (Li et al., 2009), allowing maximal two mis-
matches per read. Only the uniquely mapped reads were retained
for further analysis in this study. Gene and genome coverage
FIGURE 1 | Gene coverage and RNA integrity of RNA sequencing data. (A) Gene coverage is the proportion of a gene region covered by RNA-seq reads
and binned with an interval of 10%. Each gene belongs to one of the bin. (B) Distribution of RNA-seq reads along gene bodies.
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analysis were calculated by SOAPcoverage. For each transcript,
Reads Per Kilobase per Million mapped reads (RPKM) were cal-
culated to evaluate the expression level. The gene expression
change was estimated using NOISeq (Tarazona et al., 2011).
Genes with two or more fold expression change and NOISeq
q-value ≥ 0.6 were defined as the differentially expressed (DE)
genes. Gene ontology (GO) and pathway analysis for DE genes
were performed using the tool DAVID (Huang Da et al., 2009a,b).
Gene Set Enrichment Analysis (Mootha et al., 2003; Subramanian
et al., 2005) was performed using the gene sets of oncogenic sig-
nature (C6) and computational gene sets (C4)—cancer modules
from cancer-oriented microarray data, BDE-209 or DMSO treat-
ment as the phenotype data, the expression profiles as the data
set. Metric for ranking genes was set to Diff_of_classes. Other
parameters used default values. All the gene sets were curated by
MSigDB database v4.0.
RESULTS
GENE EXPRESSION PROFILING OF HUMAN EMBRYONIC KIDNEY CELL
HEK293T WITH BDE-209 TREATMENT
In order to explore the effects of PBDEs on gene expression in
HEK293T cell, we employed RNA-seq technology to obtain the
global gene expression profiles of HEK293T cell treated with
BDE-209 of environmental relevant concentration (10−6 M). We
also generated transcriptomic profiles of HEK293T cell treated
with the solvent DMSO (10−3 M) and normal medium as nega-
tive control, respectively. Pairwise comparison of the gene expres-
sion profiles of the three samples will allow us not only to analyze
the impacts of BDE-209 and DMSO alone on gene expression but
also the additive effects of two organic chemicals. More than 86%
of reads were mapped to the reference genome (Table S1). The
percentage of N (ambiguous nucleotide) at each read position is
extremely low (Figure S1). RNA integrity examination showed no
obvious degradation.Moreover, the sequencing reads reach a high
gene coverage such that more than 60% of the annotated genes
have a coverage rate higher than 60% (Figure 1). Taken together,
our sequencing data well represent expressed genes and reflect the
expression level of genes.
BDE-209 EXPOSURE LEADING TO PERTURBATION IN NUCLEOSOME
ORGANIZATION
We compared the transcriptomic profiles between BDE and the
solvent DMSO samples, and identified 94 statistically signifi-
cantly differentially expressed genes, 62 up-regulated genes and
32 down-regulated genes (Table S2). The functional analysis of
these genes found that they were enriched in nucleosome orga-
nization related biological process GO terms, including chromo-
some organization, nucleosome organization, DNA packaging,
etc. Interestingly, these genes are also enriched in chromatin
or nucleosome related cellular component GO terms, including
FIGURE 2 | Enriched GO terms of differentially expressed genes
between BDE-209 and DMSO samples. Biological process GO terms
(pink bars) are mainly related to chromatin remodeling such as nucleosome
organization, nucleosome assembly, DNA packaging, etc. Cellular
component GO terms (blue bars) are also largely located in chromosome,
nucleosome, etc.
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FIGURE 3 | Only small portion of genes are common among the three
lists of differentially expressed genes from pairwise comparisons of
the three samples. The three lists of genes have only one gene in
common. There are only about 20 common genes (∼25%) shared by each
two of the gene sets, respectively.
chromosome part, nucleosome, etc. (Figure 2). The impacts on
nucleosome organization could be largely due to the gene clus-
ters encoding histones that were differentially expressed in the
BDE-209 treatment (Table S2). Nucleosome occupancy controls
the accessibility of DNA sequences and regulates the binding
of transcription factors to their target sites. Thus, nucleosome
positioning affects a variety of biological processes including
DNA duplication, DNA repair, transcription, and more. This
indicates that BDE-209 is likely an epigenetic factor regulating
gene expression through nucleosome remodeling. Further anal-
ysis found that the differentially expressed genes were enriched
in the pathway systemic lupus erythematosus (p-value = 1e-
5.32). The KEGG pathway annotation shows that nucleosome
and histone gene clusters are the upstream factors in the path-
way systemic lupus erythematosus. Therefore, the perturbation
of BDE-209 to systemic lupus erythematosus is likely attributed
to the differentially expressed gene clusters encoding histones in
the BDE-209 treatment (Table S2).
EFFECTS OF BDE-209 DISSOLVED IN DMSO ON GENE EXPRESSION IS
NOT ADDITIVE EFFECTS OF BDE-209 AND DMSO
DMSO is a colorless and odorless organosulfur compound that
is an important organic solvent. It is also a toxic chemical.
Comparison of the gene expression profiles between DMSO
and the negative control (normal medium only) samples iden-
tified 117 significantly differentially expressed genes (defined
gene Set I hereinafter), 72 up-regulated genes and 45 down-
regulated genes. Similarly, we obtained 96 significantly differen-
tially expressed genes (defined gene Set II hereinafter) between
BDE-209 dissolved in DMSO and the negative control samples,
54 up-regulated genes and 42 down-regulated genes. We defined
the above identified 94 significantly differentially expressed genes
between BDE-209 dissolved in DMSO and DMSO samples as
gene Set III. There are only about 20 common genes (∼25%)
shared by each two of the gene sets, respectively (Figure 3).
Gene Set III should represent the effect of BDE-209 alone on
gene expression in principle. Gene Set II should reflect the
combined effect of BDE-209 and DMSO. However, less than
half genes of Set II overlapped with the union of gene Set
I and III (Figure 3). This suggests that BDE-209 dissolved in
DMSO has a more pronounced effect than simply additive effects
of BDE-209 and DMSO alone. Different solvents, for exam-
ple, Tween 20 solution (Wang et al., 2011a), corn oil (Szabo
et al., 2009), and ethanol (Ibhazehiebo et al., 2011), were used
to dissolve PBDEs in studies of the effects on gene expres-
sion. This raises a caveat that one should set up an appropri-
ate control to investigate the effect of a compound on gene
expression.
CARCINOGENIC POTENTIAL OF BDE-209
The standard 2-year rodent bioassays found dose-related increase
in liver and thyroid tumors in both rats and mice with deca-
BDE treatment (NTP, 1986). However, no statistically significant
increases in tumors in an earlier bioassay in rats (Kociba et al.,
1975). To fully test the carcinogenic potential effects of BDE-209
in HEK293T cells, we performed gene set enrichment analysis
(GSEA) using all cancer-related gene sets curated by the molecu-
lar signatures database (MSigDB). The results show that the gene
sets of two cancer modules (module 337 and 352) are positively
correlated with BDE-209 treatment when compared with DMSO
treatment (Figure 4). The gene sets of cancer modules were com-
piled from a large number of resources by mining published
cancer-related microarray data (Segal et al., 2004). According to
their functional annotation in MSigDB, the gene set of cancer
module 337 play an important role in nucleotide metabolism.
Their expression changes are involved in liver cancer, hemato-
logic cancer and lung cancer. The gene set of cancer module 352
regulate nuclear pore complex. Their expression changes are cor-
related with hematologic cancer. The similar GSEA analysis found
that gene sets of cancer modules 115 and 133 were enrichment
in DMSO treatment when compared with the negative control
(Figure 4). These gene sets have functions in prostate cancer, B
lymphoma, and neurotumors. In contrast, the gene sets of can-
cer modules 150 and 320 are positively correlated with BDE-209
treatment when compared with the negative control (Figure 4).
The gene sets of cancer modules 150 and 320 regulate transla-
tion elongation andMphase, respectively. The expression changes
are related to various tumors, including prostate cancer, hemato-
logic cancer, liver cancer, lung tumors, and B lymphoma. Taken
together, BDE-209 exposure has carcinogenicity. Notably, there is
no common gene sets among the gene sets positively correlated
to each treatment. This implies that the carcinogenic potential of
BDE-209 dissolved in DMSO is not simple additive potentials of
BDE-209 and DMSO alone. It also suggests that one should take
into account the dissolvent in the studies on the toxic effects of
PBDEs.
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FIGURE 4 | Correlation between the enrichment of oncogenic signature
genes and BDE-209 exposure. Top panel: genes are ranked by the
expression ratio of BDE-209 dissolved in DMSO sample over DMSO sample.
The genes of cancer module 337 and 352 are positively correlated with
BDE-209 exposure. Middle panel: genes are ranked by the expression ratio of
DMSO sample over the negative control sample. The genes of cancer
module 115 and 133 are positively correlated with DMSO treatment. Bottom
panel: genes are ranked by the expression ratio of BDE-209 dissolved in
DMSO sample over the negative control sample. The genes of cancer
module 150 and 320 are positively correlated with BDE-209 exposure.
DISCUSSION
PBDEs consist of more than 200 possible congeners. The com-
mercial use of PBDEs as flame-retardant additives is actual in a
mixture of congeners that are slowly released over time. PBDEs
with different levels of bromination possess distinct proper-
ties. The fully brominated deca-BDE congeners are likely one
of the least bioactive PBDEs because they are relatively poorly
absorbed, rapidly removed, and not bioaccumulative (Hooper
and McDonald, 2000). In contrast, PBDE congeners with lower
levels of bromination, tri- to hexa-BDES, are almost fully
absorbed, slowly degraded, and highly bioaccumulative when
compared with deca-BDEs. Therefore, an important considera-
tion is treatment time when one attempts to investigate the bona
fide toxicity of deca-BDE before its elimination. It was reported
that, when exposed to sunlight, deca-BDE could be converted to
congeners with lower levels of bromination and become bioac-
tive (Watanabe and Tatsukawa, 1987; Soderstrom et al., 2004).
Consequently, studies on the toxic effect of the lower molecu-
lar weight congeners can more closely represent that of PBDEs
in environment than deca-BDEs. Additionally, one single PBDE
congener is usually used in studies on toxicity of PBDEs. However,
the actual toxic effects of PBDE congeners leached to the environ-
ment from the commercial mixture are much more complex than
that in bioassays.
As noted earlier, many bioassays on the toxic effects of
PBDEs mainly focused on disruption of TH homeostasis and
TH-induced biological processes. In this study, we used a not TH-
related human cell HEK239T to investigate the toxic effects of
PBDEs, and discovered that PBDE exposure could affect nucle-
osome organization. Additionally, BDE-209 has carcinogenic
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potential effects in HEK293T cells. Interestingly, a previous study
showed that BDE-209 exposure can cause mouse sperm DNA
damage in a dose dependent manner (Wang et al., 2011b). This
finding suggests that PBDEs may exert different toxic effects on
different type of cells. Collectively, TH has diverse toxic effects
not limited to TH disruption as more studies are undertaken.
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